Cell and gene therapies represent the most ambitious frontier of the biologic therapy market. Rather than managing symptoms, these treatments aim to correct disease at its genetic or cellular source — potentially offering one-time cures for conditions that previously required lifelong management. CAR-T therapies for blood cancers, gene therapies for inherited disorders, and emerging...
